JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 1 128-130
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiting, J. H.
Right arrow Articles by Morton, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiting, J. H., Jr.
Right arrow Articles by Morton, K. A.

Cerebrovascular Accident Associated with Dipyridamole Thallium-201 Myocardial Imaging: Case Report

John H. Whiting, Jr., Frederick L. Datz, Frank V. Gabor, Shawn R. Jones and Kathryn A. Morton

Department of Radiology, Division of Nuclear Medicine, University of Utah School of Medicine, Salt Lake City, Utah

Correspondence: For correspondence or reprints contact: Frederick L. Datz, MD, Director of Nuclear Medicine, Department of Radiology, University of Utah Medical Center, Salt Lake City, UT 84132.

ABSTRACT

A patient with known aortoiliac occlusive disease and hypertension suffered a cerebrovascular accident 6.5 min after the administration of intravenous dipyridamole during a 201Tl myocardial study. Despite aminophylline administration, the patient developed a completed stroke. The mechanism most likely responsible for precipitating this patient's stroke is dipyridamole-induced vascular steal. Although dipyridamole-201Tl myocardial imaging is relatively free of major complications, the morbidity and mortality associated with a cerebrovascular accident is significant. The possibility of precipitating a cerebrovascular accident during dipyridamole-201Tl imaging should be considered in all patients with significant risk factors for stroke before performing a dipyridamole cardiac study.




This article has been cited by other articles:


Home page
StrokeHome page
H. Ito, T. Kinoshita, Y. Tamura, I. Yokoyama, and H. Iida
Effect of Intravenous Dipyridamole on Cerebral Blood Flow in Humans : A PET Study
Stroke, August 1, 1999; 30(8): 1616 - 1620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.